Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Zahra Mahmoudjafari

United States

Research Interests

Explore related searches

Articles (21)

Collaborators (7)

Zena Chahine

Assistant professor

University of Kentucky

UNITED STATES

Kamakshi Rao

UNITED STATES

Barry A. Paul

Assistant Professor

Levine Cancer Institute

UNITED STATES

Rebecca Gardner

Associate Member

St. Jude Children's Research Hospital

UNITED STATES

Muhammad Umair Mushtaq

Assistant Professor of Medicine

University of Kansas Medical Center

UNITED STATES

Yun Kyoung Ryu Tiger

Assistant Professor of Medicien

Rutgers Cancer Institute of New Jersey

UNITED STATES

Jeries KORT

Assistant Professor

University of Kansas Cancer Center

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zahra Mahmoudjafari

Research Interests

Explore related searches

Articles (21)

Collaborators (7)

Zena Chahine

Kamakshi Rao

Barry A. Paul

Rebecca Gardner

Muhammad Umair Mushtaq

Yun Kyoung Ryu Tiger

Jeries KORT

Make your next move.

Zahra Mahmoudjafari

Research Interests

Explore related searches

Articles (21)

Sequencing BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison of CAR T-Cell Therapy and Bispecific Antibodies

Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity

The ClinicalTrials.gov Landscape of Multiple Myeloma Clinical Trials: A 20-Year Analysis of Geographic Distribution and Growth Patterns: USMIRC Analysis

Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC

From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs

High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis

Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients

Maintenance Strategies in High-Risk Myeloma: A Multicenter Comparison of Bortezomib–Lenalidomide Versus Lenalidomide Alone: A USMIRC Multicenter Analysis

Immune Effector Cell-Associated HLH-Like Syndrome (IEC-HS) in CAR-T and TCE-Treated Myeloma and B-Cell Malignancies: Insights from a Pharmacovigilance Study

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group

BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment

Exploring the Global Landscape of Open-Access Publication Models and Their Correlation With the Impact Factor in the Field of Hematology/Oncology

CAR-T Access Disparities for Multiple Myeloma in the Midwest: A Social Determinants of Health Perspective

Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 Trial

Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells

Teclistamab Dosing Strategies in Relapsed/Refractory Myeloma: A Real-World Comparison of Weekly and Biweekly Versus Fixed Intervals.

Budget impact of introducing glofitamab for treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy in the United States

Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials

Glofitamab results in cost savings versus epcoritamab in relapsed/refractory diffuse large B-cell lymphoma: a total cost of care analysis ‡

Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease

Response to Letters to the Editor: “Assessment of attrition and retention factors in the oncology pharmacy workforce: Results of the oncology pharmacy workforce survey”

Collaborators (7)

Zena Chahine

Kamakshi Rao

Barry A. Paul

Rebecca Gardner

Muhammad Umair Mushtaq

Yun Kyoung Ryu Tiger

Jeries KORT

Make your next move.